| Literature DB >> 24960166 |
Tomohiro Banno1, Miroslav Blumenberg2.
Abstract
Epidermis, a continuously self-renewing and differentiating organ, produces a protective stratum corneum that shields us from external chemical, physical and microbial threats. Epidermal differentiation is a multi-step process regulated by influences, some unknown, others insufficiently explored. Detachment of keratinocytes from the basement membrane is one such pro-differentiation stimulus. Here, we define the transcriptional changes during differentiation, especially those caused by detachment from the substratum. Using comprehensive transcriptional profiling, we revisited the effects of detachment as a differentiation signal to keratinocytes. We identified the genes regulated by detachment, the corresponding ontological categories and, using metaanalysis, compared the genes and categories to those regulated by other pro-differentiating stimuli. We identified 762 genes overexpressed in suspended keratinocyte, including known and novel differentiation markers, and 1427 in attached cells, including basal layer markers. Detachment induced epidermis development, cornification and desmosomal genes, but also innate immunity, proliferation inhibitors, transcription regulators and MAPKs; conversely the attached cells overexpressed cell cycle, anchoring, motility, splicing and mitochondrial genes, and both positive and negative regulators of apoptosis. Metaanalysis identified which detachment-regulated categories overlap with those induced by suprabasal location in vivo, by reaching confluency in vitro, and by inhibition of JUN kinases. Attached and in vivo basal cells shared overexpression of mitochondrial components. Interestingly, melanosome trafficking components were also overexpressed in the attached and in vivo basal keratinocytes. These results suggest that specific pro-differentiation signals induce specific features of the keratinization process, which are in vivo orchestrated into harmonious epidermal homeostasis.Entities:
Mesh:
Year: 2014 PMID: 24960166 PMCID: PMC4069014 DOI: 10.1371/journal.pone.0100279
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Suspended and attached keratinocytes.
Cultures 24 and 48
Ontological categories overexpressed in attached keratinocytes.
|
|
|
| arachidonate 12-lipoxygenase, 12R type | adrenomedullin |
| BARX homeobox 2 | CD24 molecule CD24 molecule-like 4 |
| cellular retinoic acid binding protein 2 | cytochrome P450, polypeptide 1 |
| corneodesmosin ** | defensin, beta 1 ∼∼ |
| cystatin A (stefin A) ** | defensin, beta 4 ∼∼ |
| cystatin E/M | histone cluster 1, H2bi |
| desmoplakin ** | histone cluster 1, H2bj |
| E74-like factor 5 (ets domain transcription factor) | histone cluster 1, H2bk |
| envoplakin ** | histone cluster 2, H2be |
| epiregulin ** | interleukin 6 receptor |
| fatty acid binding protein 5 (psoriasis-associated) | jun oncogene |
| filaggrin ** | mitogen-activated protein kinase 14 |
| forkhead box N1 ** | NFkB inhibitor, alpha |
| involucrin ** | protein phosphatase 1D, delta isoform |
| kallikrein-related peptidase 7 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
| keratin 1 ** | S100 calcium binding protein A12 |
| keratin 10 ** | S100 calcium binding protein A7 |
| keratin 13 | thrombomodulin |
| keratin 16 | tribbles homolog 1 |
| keratin 17 | v-fos FBJ oncogene homolog |
| keratin 2 ** | Wiskott-Aldrich syndrome-like |
| keratin 31 | |
| keratin 9 ** |
|
| Kruppel-like factor 4 | adrenomedullin |
| late cornified envelope 2B ** | alpha-2-glycoprotein 1 |
| loricrin ** | B-cell CLL/lymphoma 6 |
| MAX interactor 1 ** | B-cell translocation gene 1, anti-proliferative |
| ovo-like 1 | bone morphogenetic protein 2 |
| periplakin ** | BTG family, member 2 |
| peroxisome proliferator-activated receptor delta ** | C/EBPalpha |
| S100 calcium binding protein A7 ** | CD24 molecule |
| sciellin ** | CDK inhibitor 1B (p27, Kip1) |
| serine peptidase inhibitor, Kazal type 5 | CDK inhibitor 1C (p57, Kip2) |
| SMAD specific E3 ubiquitin protein ligase 1 | formin binding protein 1 |
| small proline-rich protein 1A ** | gamma-glutamyl hydrolase |
| small proline-rich protein 1B (cornifin) ** | glucosidase, beta acid |
| small proline-rich protein 2G ** | hyaluronoglucosaminidase 1 |
| small proline-rich protein 2D ** | iduronate 2-sulfatase |
| thioredoxin interacting protein ** | palmitoyl-protein thioesterase 2 |
| TIMP metallopeptidase inhibitor 2 ** | potassium voltage-gated channel 1 |
| transducer of ERBB2, 1 ** | sphingomyelin phosphodiesterase 1, |
| transglutaminase 1 (K epidermal type I) ** | tripartite motif-containing 23 |
| transglutaminase 3 (E polypeptide) ** | ubiquitin specific peptidase 4 (proto-oncogene) |
| transglutaminase 5 | ubiquitin specific peptidase 6 (Tre-2 oncogene) |
| transmembrane protein 115 ** | |
| tribbles homolog 1 (Drosophila) ** |
|
| UDP-glucose ceramide glucosyltransferase | adrenomedullin |
| v-erb-b2 oncogene homolog 2 | carbonic anhydrase II |
| zinc finger and BTB domain containing 17 | CD24 molecule |
| crystallin, alpha B | |
|
| cyclin E1 |
| corneodesmosin | dual specificity phosphatase 1 |
| desmocollin 1 | E1A binding protein p300 |
| desmocollin 2 | GATA binding protein 3 |
| desmoglein 1 | heme oxygenase (decycling) 1 |
| desmoplakin | interleukin 1 receptor antagonist |
| envoplakin | interleukin 6 receptor |
| junction plakoglobin | jun B proto-oncogene |
| periplakin | PPAR gamma |
| plakophilin 1 | phosphatase and tensin homolog |
| plakophilin 3 | protease, serine, 8 |
| CDK4 inhibitor 2B (p15) | regulator of calcineurin 1 |
| epiregulin | retinoid X receptor, alpha |
| heme oxygenase (decycling) 1 | ribosomal protein S6 kinase, 70 kDa, polypeptide 1 |
| hyaluronoglucosaminidase 1 | thioredoxin interacting protein |
| insulin-like growth factor binding protein 5 | v-erb-b2 oncogene homolog 2 |
| jumonji, AT rich interactive domain 2 | v-fos FBJ oncogene homolog |
| K(lysine) acetyltransferase 2B | |
| keratin 4 |
|
| Kruppel-like factor 10 | C/EBPalpha |
| Kruppel-like factor 4 | MAP kinase interacting serine/threonine kinase 2 |
| vacuolar protein sorting 4 homolog B | mitogen-activated protein kinase 3 |
| jun oncogene | |
| mitogen-activated protein kinase 13 | |
| mitogen-activated protein kinase 14 | |
| mitogen-activated protein kinase 6 | |
| mitogen-activated protein kinase 7 | |
| mitogen-activated protein kinase kinase 3 | |
| mitogen-activated protein kinase kinase kinase 4 |
a) Ectoderm development. Known components of the cornified envelopes are marked with double asterisks. b) Desmosomal; proteins. Some of these are also noted as ectoderm development markers. c) Response to bacteria; the two defensins are marked with tildes. d) Negative regulators of proliferation. e) Genes responding to steroid hormone regulation. f) Components of the MAPK signaling cascades.
Ontological categories overexpressed in suspended keratinocytes.
| a) Cell adhesion | b) Positive regulators of motility |
| ADAM metallopeptidase domain 9 | ADAM metallopeptidase domain 9 |
| CD44 | SMAD family member 3 |
| LIM and senescent cell antigen-like domains 1 | SP100 nuclear antigen |
| actinin, alpha 1 | actinin, alpha 1 |
| catenin, beta 1, 88 kDa | actinin, alpha 4 |
| collagen, type XVII, alpha 1 | cAMP responsive element binding protein 3 |
| connective tissue growth factor | cadherin 13, H-cadherin (heart) |
| fibronectin 1 | chloride intracellular channel 4 |
| integrin beta 1 binding protein 1 | coagulation factor II (thrombin) receptor |
| integrin, alpha 2 | coagulation factor II (thrombin) receptor-like 1 |
| integrin, alpha 3 | coagulation factor III (thromboplastin) |
| integrin, alpha 6 | epidermal growth factor receptor |
| integrin, alpha V | histone deacetylase 9 |
| integrin, beta 1 | insulin receptor substrate 1 |
| integrin, beta 4 | insulin-like growth factor 1 receptor |
| integrin, beta 5 | integrin, alpha 2 |
| integrin, beta 6 | integrin-linked kinase |
| integrin-linked kinase | gp130, oncostatin M receptor |
| laminin, alpha 5 | jagged 1 |
| laminin, beta 1 | jagged 2 |
| laminin, gamma 1 (formerly LAMB2) | laminin, alpha 3 |
| nidogen 1 | laminin, alpha 5 |
| polycystic kidney disease 2 | laminin, beta 1 |
| protein tyrosine phosphatase, receptor type, K | matrix metallopeptidase 9 |
| sarcoglycan, epsilon | mitogen-activated protein kinase kinase 1 |
| thyroid hormone receptor interactor 6 | neurofibromin 2 (merlin) |
| platelet-derived growth factor alpha polypeptide | |
| podoplanin | |
| protein tyrosine phosphatase, receptor type, K | |
| related RAS (r-ras) oncogene | |
| related RAS (r-ras) oncogene2 | |
| reticulon 4 | |
| scavenger receptor class B, member 1 | |
| serpin peptidase inhibitor, clade E (nexin) | |
| thrombospondin 1 | |
| thyroid hormone receptor interactor 6 | |
| transforming growth factor, beta 1 | |
| tropomyosin 1 (alpha) | |
| v-akt oncogene homolog 1 | |
| vascular endothelial growth factor C | |
| vinculin |
a) Cell adhesion proteins. Note the many integrins in this category. b) Positive regulators of cell motility. Note the components of the extracellular matrix and basement membrane.
Metaanalysis comparing the ontological categories overexpressed by inducers of keratinocyte differentiation.
| Category cluster | GO Category | Suspended | Suprabasal | SP600125 | Confluent | Conf-EGF |
|
| ∼ectoderm development | 3.E-16 | 5.E-03 | 7.E-08 | 3.E-34 | 1.E-27 |
| ∼epidermis development | 3.E-15 | 2.E-03 | 1.E-07 | 9.E-33 | 1.E-28 | |
| ∼epidermal cell differentiation | 2.E-12 | 1.E-02 | 7.E-04 | 4.E-29 | 1.E-21 | |
| ∼cornified envelope | 4.E-13 | 2.E-04 | 2.E-04 | 1.E-23 | 1.E-16 | |
|
| ∼response to bacterium | 1.E-03 | 8.E-03 | 5.E-02 | 7.E-02 | |
| ∼response to molecule of bacterial origin | 8.E-03 | 1.E-03 | ||||
| ∼response to lipopolysaccharide | 1.E-02 | 4.E-03 | ||||
| ∼inflammatory response | 4.E-02 | 4.E-02 | ||||
|
| ∼fatty acid metabolic process | 3.E-02 | 4.E-03 | 3.E-02 | 5.E-02 | 8.E-02 |
| ∼cellular lipid catabolic process | 1.E-02 | 3.E-02 | 1.E-01 | 9.E-02 | ||
| ∼lipid localization | 4.E-03 | 1.E-02 | 6.E-02 | |||
| ∼lipid transport | 4.E-03 | 2.E-02 | 7.E-02 | |||
|
| ∼sterol biosynthetic process | 9.E-02 | 3.E-03 | 2.E-03 | ||
| ∼steroid metabolic process | 2.E-02 | 5.E-03 | 7.E-03 | |||
| ∼sterol metabolic process | 6.E-02 | 3.E-03 | 3.E-02 | |||
| ∼response to steroid hormone stimulus | 1.E-03 | 7.E-03 | ||||
|
| ∼regulation of apoptosis | 1.E-03 | 6.E-02 | 2.E-09 | 2.E-02 | |
| ∼regulation of programmed cell death | 2.E-03 | 7.E-02 | 1.E-09 | 3.E-02 | ||
| ∼regulation of cell death | 2.E-03 | 7.E-02 | 2.E-09 | 3.E-02 | ||
| ∼positive regulation of apoptosis | 3.E-03 | 2.E-07 | ||||
|
| ∼membrane-enclosed lumen | 9.E-03 | 2.E-04 | 2.E-19 | ||
| ∼intracellular organelle lumen | 6.E-03 | 6.E-04 | 2.E-19 | |||
| ∼organelle lumen | 8.E-03 | 3.E-04 | 4.E-19 | |||
| ∼vacuole | 8.E-06 | 5.E-04 | 8.E-03 | 6.E-03 | ||
|
| ∼regulation of transcription RNA pol II promoter | 1.E-08 | 2.E-10 | |||
| ∼transcription factor binding | 2.E-06 | 1.E-11 | ||||
| ∼chromatin | 5.E-09 | 2.E-08 | ||||
| ∼regulation of nucleoside, nucleotide metabolism | 1.E-09 | 4.E-07 | ||||
|
| ∼endopeptidase inhibitor activity | 5.E-02 | 7.E-03 | 5.E-02 | 3.E-08 | 2.E-05 |
| ∼peptidase inhibitor activity | 7.E-02 | 1.E-02 | 8.E-02 | 6.E-08 | 4.E-05 | |
| ∼serine-type endopeptidase activity | 2.E-02 | 7.E-08 | 1.E-05 | |||
| ∼serine-type peptidase activity | 1.E-02 | 2.E-07 | 2.E-05 | |||
|
| ∼phosphorylation | 7.E-06 | 4.E-02 | 5.E-06 | ||
| ∼protein amino acid phosphorylation | 1.E-05 | 5.E-05 | ||||
| ∼protein kinase activity | 2.E-05 | 9.E-03 | ||||
| ∼protein serine/threonine kinase activity | 1.E-04 | 2.E-02 | ||||
|
| ∼protein amino acid dephosphorylation | 5.E-03 | 5.E-02 | |||
| ∼phosphoprotein phosphatase activity | 1.E-02 | 2.E-02 | ||||
| ∼phosphatase activity | 9.E-03 | 3.E-02 | ||||
| ∼dephosphorylation | 8.E-03 | 6.E-02 | ||||
|
| ∼regulation of cell proliferation | 3.E-04 | 1.E-10 | |||
| ∼negative regulation of cell proliferation | 7.E-05 | 3.E-07 | ||||
| ∼regulation of cell cycle | 3.E-04 | 1.E-02 | ||||
| ∼negative regulation of growth | 2.E-02 | 6.E-02 | ||||
|
| ∼cell motion | 2.E-03 | 3.E-04 | |||
| ∼cell migration | 9.E-04 | 6.E-04 | ||||
| ∼cell motility | 2.E-03 | 2.E-03 | ||||
| ∼localization of cell | 2.E-03 | 2.E-03 | ||||
|
| ∼nuclear lumen | 9.E-04 | 2.E-03 | 1.E-20 | ||
| ∼nucleoplasm | 6.E-03 | 3.E-03 | 3.E-15 | |||
| ∼nucleoplasm part | 1.E-02 | 2.E-02 | 1.E-11 | |||
| ∼nucleolus | 9.E-02 | 5.E-02 | 3.E-07 | |||
|
| ∼response to oxidative stress | 6.E-03 | 2.E-04 | 8.E-02 | 2.E-02 | |
| ∼response to reactive oxygen species | 3.E-02 | 3.E-04 | 9.E-02 | 4.E-02 | ||
| ∼response to hydrogen peroxide | 5.E-02 | 2.E-04 | ||||
| ∼response to hypoxia | 5.E-03 | 6.E-02 | 5.E-02 |
The p-values for each category are given for suspended, suprabasal, SP600125 JNK inhibitor treated and confluent keratinocytes in the absence or presence of EGF are given. Gray fields indicate that the given category did not reach statistical significance.
Metaanalysis comparing the ontological categories overexpressed in undifferentiated keratinocytes.
| Category Clusters | GO Categories | Attached | Basal | No SP600125 | Sub-Conf. | Sub-C. -EGF |
|
| ∼cell cycle | 9.E-19 | 2.E-03 | 2.E-07 | 1.E-21 | 2.E-30 |
| ∼cell cycle process | 2.E-18 | 7.E-04 | 1.E-06 | 1.E-21 | 1.E-28 | |
| ∼mitotic cell cycle | 1.E-17 | 3.E-03 | 1.E-07 | 8.E-22 | 2.E-26 | |
| ∼cell cycle phase | 1.E-12 | 1.E-02 | 5.E-06 | 1.E-21 | 1.E-31 | |
|
| ∼DNA metabolic process | 5.E-14 | 9.E-03 | 5.E-03 | 2.E-07 | 4.E-16 |
| ∼DNA replication | 5.E-08 | 5.E-05 | 4.E-03 | 1.E-05 | 6.E-09 | |
| ∼response to DNA damage stimulus | 8.E-09 | 9.E-02 | 8.E-04 | 1.E-03 | 3.E-11 | |
| ∼DNA repair | 1.E-07 | 5.E-02 | 5.E-03 | 3.E-11 | ||
|
| ∼cell-substrate junction | 1.E-07 | 7.E-07 | 7.E-02 | 1.E-04 | |
| ∼cell adhesion | 1.E-04 | 3.E-05 | 5.E-06 | 6.E-05 | ||
| ∼biological adhesion | 1.E-04 | 3.E-05 | 5.E-06 | 6.E-05 | ||
| ∼cell-substrate adhesion | 2.E-06 | 9.E-05 | 7.E-04 | 5.E-03 | ||
|
| ∼basolateral plasma membrane | 5.E-06 | 5.E-09 | 1.E-02 | 1.E-03 | |
|
| ∼basement membrane | 5.E-05 | 2.E-07 | 8.E-04 | 3.E-06 | |
| ∼basal lamina | 1.E-02 | 2.E-04 | 4.E-02 | 3.E-03 | ||
| ∼basal part of cell | 4.E-03 | 2.E-02 | 3.E-02 | |||
|
| ∼extracellular matrix part | 7.E-04 | 8.E-08 | 3.E-04 | 7.E-05 | |
| ∼extracellular matrix | 2.E-02 | 1.E-06 | 4.E-03 | 2.E-02 | 5.E-05 | |
| ∼extracellular matrix binding | 2.E-03 | 7.E-05 | 1.E-03 | 2.E-02 | ||
| ∼collagen | 9.E-02 | 5.E-04 | 3.E-02 | 6.E-02 | ||
|
| ∼membrane-enclosed lumen | 3.E-34 | 4.E-06 | 5.E-12 | 9.E-07 | 2.E-10 |
| ∼organelle lumen | 2.E-34 | 2.E-06 | 2.E-11 | 1.E-06 | 5.E-10 | |
| ∼intracellular organelle lumen | 1.E-32 | 4.E-06 | 5.E-10 | 1.E-05 | 9.E-09 | |
| ∼endoplasmic reticulum | 1.E-04 | 3.E-03 | 8.E-04 | 3.E-04 | 2.E-02 | |
|
| ∼nuclear lumen | 1.E-22 | 8.E-04 | 5.E-09 | 5.E-03 | 8.E-07 |
| ∼nucleoplasm | 2.E-16 | 3.E-04 | 4.E-08 | 4.E-04 | 4.E-07 | |
| ∼chromosomal part | 6.E-08 | 4.E-04 | 6.E-11 | 7.E-15 | ||
| ∼nucleolus | 4.E-09 | 4.E-02 | 2.E-02 | 8.E-02 | ||
|
| ∼chromosome | 1.E-09 | 3.E-04 | 9.E-11 | 8.E-17 | |
| ∼response to vitamin | 2.E-03 | 9.E-04 | 5.E-05 | 5.E-03 | 5.E-03 | |
| ∼negative regulation of gene expression | 2.E-03 | 9.E-03 | 9.E-04 | |||
| ∼transcription factor binding | 2.E-02 | 1.E-03 | 4.E-03 | |||
|
| ∼RNA splicing, via transesterification reactions | 2.E-16 | 4.E-02 | 2.E-02 | ||
| ∼RNA splicing, with bulged adenosine as nucleophile | 2.E-16 | 4.E-02 | 2.E-02 | |||
| ∼nuclear mRNA splicing, via spliceosome | 2.E-16 | 4.E-02 | 2.E-02 | |||
| ∼RNA binding | 2.E-16 | 8.E-02 | ||||
|
| ∼ribonucleoprotein complex | 3.E-19 | 4.E-02 | |||
| ∼protein complex assembly | 3.E-10 | 6.E-03 | 4.E-03 | |||
| ∼protein complex biogenesis | 3.E-10 | 6.E-03 | 4.E-03 | |||
| ∼ribosome biogenesis | 1.E-06 | |||||
|
| ∼negative regulation of protein metabolic process | 3.E-08 | 2.E-03 | 3.E-02 | 4.E-02 | 3.E-04 |
| ∼positive regulation of protein metabolic process | 3.E-04 | 2.E-03 | 1.E-03 | 4.E-04 | 1.E-03 | |
| ∼negative regulation of protein modification process | 7.E-07 | 9.E-04 | 5.E-03 | 2.E-04 | ||
| ∼regulation of protein modification process | 4.E-04 | 7.E-03 | 2.E-02 | 6.E-04 | 3.E-04 | |
|
| ∼regulation of ubiquitin-protein ligase during cell cycle | 8.E-07 | 4.E-02 | 9.E-05 | 9.E-04 | |
| ∼regulation of ubiquitin-protein ligase activity | 1.E-06 | 7.E-02 | 2.E-04 | 6.E-04 | ||
| ∼regulation of protein ubiquitination | 8.E-06 | 5.E-02 | 1.E-01 | 4.E-04 | 8.E-04 | |
| ∼positive regulation of ubiquitin-protein ligase activity | 1.E-05 | 9.E-02 | 4.E-04 | 8.E-03 | ||
|
| ∼intracellular signaling cascade | 3.E-03 | 6.E-02 | 3.E-05 | 1.E-01 | 4.E-02 |
| ∼kinase binding | 1.E-04 | 4.E-03 | 5.E-02 | 3.E-03 | ||
| ∼regulation of kinase activity | 4.E-03 | 3.E-03 | 7.E-02 | 7.E-04 | ||
| ∼regulation of protein kinase activity | 9.E-03 | 4.E-03 | 6.E-02 | 2.E-03 | ||
|
| ∼cytoskeleton | 1.E-08 | 6.E-03 | 3.E-04 | 7.E-06 | 3.E-08 |
| ∼cytoskeleton organization | 2.E-08 | 3.E-04 | 1.E-02 | 1.E-03 | 7.E-10 | |
| ∼cytoskeletal part | 4.E-05 | 9.E-02 | 2.E-02 | 7.E-08 | 9.E-07 | |
| ∼structural constituent of cytoskeleton | 2.E-04 | 4.E-05 | ||||
|
| ∼microtubule cytoskeleton | 4.E-06 | 7.E-04 | 2.E-11 | 1.E-11 | |
| ∼actin cytoskeleton | 1.E-07 | 4.E-03 | 7.E-02 | |||
| ∼microtubule cytoskeleton organization | 2.E-05 | 8.E-05 | 3.E-08 | |||
| ∼cytoskeletal protein binding | 2.E-04 | 7.E-03 | 4.E-02 | 4.E-02 | 2.E-04 | |
|
| ∼regulation of cell motion | 6.E-07 | 2.E-04 | 8.E-04 | 2.E-02 | 5.E-04 |
| ∼regulation of cell migration | 4.E-07 | 4.E-04 | 3.E-03 | 5.E-03 | ||
| ∼positive regulation of cell motion | 2.E-06 | 2.E-02 | 6.E-03 | 1.E-02 | 2.E-03 | |
| ∼positive regulation of cell migration | 9.E-07 | 1.E-02 | 2.E-02 | 7.E-02 | 2.E-03 | |
|
| ∼mitochondrion | 4.E-14 | 5.E-05 | 7.E-03 | ||
| ∼mitochondrial part | 9.E-13 | 3.E-02 | ||||
| ∼mitochondrion organization | 6.E-07 | 4.E-03 | ||||
| ∼generation of precursor metabolites and energy | 8.E-09 | |||||
|
| ∼melanosome | 3.E-12 | 1.E-03 | 4.E-07 | 7.E-02 | |
| ∼pigment granule | 3.E-12 | 1.E-03 | 4.E-07 | 7.E-02 | ||
| ∼pigment metabolic process | 2.E-03 | 5.E-02 | ||||
| ∼pigment biosynthetic process | 2.E-03 | 8.E-02 | ||||
|
| ∼regulation of cell death | 1.E-05 | 1.E-03 | 5.E-06 | 2.E-02 | 6.E-02 |
| ∼regulation of programmed cell death | 3.E-05 | 1.E-03 | 4.E-06 | 2.E-02 | 6.E-02 | |
| ∼anti-apoptosis | 2.E-03 | 4.E-07 | 4.E-02 | |||
| ∼negative regulation of cell death | 9.E-05 | 7.E-02 | 2.E-05 |
The p-values for each category are given for attached, basal, JNK inhibitor untreated and subconfluent keratinocytes in the absence or presence of EGF are given. Gray fields indicate that the given category did not reach statistical significance.